Disulfiram (Antabuse): How Alcohol-Deterrent Medication Works in Recovery

Disulfiram (Antabuse) is the oldest alcohol-deterrent medication still in clinical use, working by blocking the enzyme that clears a toxic alcohol byproduct from the body, which triggers a rapid and unpleasant physical reaction if someone drinks. The research shows it works best under supervised administration and loses its effect when taken unsupervised, which is why NICE positions it as a second-line option used alongside — never instead of — a full treatment programme.

If you’ve just been told that disulfiram — better known by its original brand name, Antabuse — might be part of your treatment plan, you probably have two questions on your mind: does it actually work, and what happens if I drink on it anyway? If you’re a family member who’s just heard a loved one mention “Antabuse” for the first time and gone straight to Google, you’re likely asking something slightly different: is this safe, and is it enough on its own?

Both questions deserve honest answers. Disulfiram is the oldest alcohol-deterrent medication still in clinical use — it has been part of alcohol treatment since the 1950s and still appears in NICE guidance today — but it is not a standalone cure. It doesn’t touch the underlying psychological, neurological or relational drivers of drinking. What it does is make drinking itself unpleasant enough, through a very specific biochemical reaction, that many people find it easier to stick to a decision they’ve already made to stay sober. This article walks through exactly how it works in the body, what the research actually shows (including where it falls short), who it’s suitable for, what the reaction feels like, and how it fits into a supervised programme like the one at Holina Rehab.

What is disulfiram and how does it actually work in the body?

Disulfiram doesn’t reduce the desire to drink in the way some other medications do. Instead, it works by sabotaging the body’s ability to process alcohol normally, so that drinking produces a rapid, unpleasant physical reaction rather than the usual effects of intoxication.

Here’s the mechanism. When you drink alcohol, your liver breaks it down in two steps. First, an enzyme converts alcohol into a compound called acetaldehyde — a toxic intermediate substance. Normally, a second enzyme called aldehyde dehydrogenase (ALDH) quickly converts that acetaldehyde into acetate, which the body can process and clear without any trouble. Disulfiram works by irreversibly inhibiting ALDH. According to the mechanism literature summarised on the NCBI Bookshelf (StatPearls, NBK459340), disulfiram blocks the ALDH1A1 enzyme by competing with NAD at a cysteine residue on the enzyme itself, effectively disabling it.

With ALDH knocked out, acetaldehyde has nowhere to go. If someone drinks while disulfiram is active in their system, acetaldehyde builds up rapidly in the blood, and that buildup is what produces the disulfiram-alcohol reaction: flushing, a throbbing headache, nausea, vomiting, tightness in the chest, a drop in blood pressure and a racing heart, often within just 10 to 30 minutes of drinking. It is this engineered, predictable unpleasantness — not a craving-blocker, not a sedative — that forms the core of how disulfiram works.

There’s a secondary mechanism worth knowing about too. Disulfiram also inhibits an enzyme called dopamine-β-hydroxylase, which may raise dopamine levels in the brain and could contribute to some reduction in cravings independent of the aversive reaction, according to the mechanism literature. But this effect is considered secondary and modest — the deterrent is psychological as much as it is pharmacological. Knowing that drinking will trigger a reaction is often enough on its own to change behaviour, even before any alcohol is consumed.

NICE Clinical Guideline CG115 (“Alcohol-use disorders: diagnosis, assessment and management,” 2011) sets out the standard clinical approach: a typical maintenance dose of 200mg per day, started at least 24 hours after the person’s last drink, to ensure no alcohol is still active in the system when the enzyme blockade begins.

Does disulfiram actually work? What the research says

This is where honesty matters more than marketing. The evidence for disulfiram is genuinely mixed, and understanding why is the key to understanding how it should be used.

The most famous study is Fuller et al.’s 1986 trial published in JAMA, “Disulfiram Treatment of Alcoholism: A Veterans Administration Cooperative Study.” This landmark, blinded trial followed 605 men across nine VA medical centres, comparing a full 250mg dose of disulfiram, a 1mg placebo-strength dose, and no disulfiram at all. The headline result surprised a lot of clinicians at the time: there was no significant difference in total abstinence rates between the three groups. However, there was an important secondary finding — among the men who did drink during the study, those taking the full disulfiram dose drank on significantly fewer days than the others. In other words, disulfiram didn’t guarantee abstinence, but it seemed to reduce the frequency of drinking episodes among people who slipped.

A more recent and more favourable picture comes from Jørgensen, Pedersen and Tønnesen’s 2011 meta-analysis in Alcoholism: Clinical and Experimental Research, which pooled data from 11 randomised controlled trials covering 1,527 patients. This analysis found that supervised disulfiram had a measurable effect on short-term abstinence, time to relapse, and total number of drinking days — but the authors were careful to note that better-quality, longer-term trials were still needed to confirm how durable these benefits are.

The detail that arguably matters most for anyone trying to make sense of disulfiram’s reputation comes from Skinner, Lahmek, Pham and Aubin’s 2014 meta-analysis in PLOS ONE, “Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis.” Their key finding was that efficacy showed up consistently in open-label, supervised trials — where someone else knew the person was taking the medication and was involved in overseeing it — but not in blinded or unsupervised trials, where no advantage over placebo was found. This is the most commonly cited explanation for why disulfiram has such a controversial reputation in addiction medicine: it appears to work specifically when someone is actively overseeing daily dosing, and to lose its effect when a person is left to take it entirely on their own.

Finally, context matters. Jonas et al.’s 2014 JAMA review, “Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings,” notes that disulfiram’s evidence base is considerably smaller than that of other approved medications — just 4 placebo-controlled trials, compared with 44 for naltrexone and 22 for acamprosate. This smaller evidence base is a significant part of why NICE positions disulfiram as a second-line option rather than a first choice.

Taken together, the research tells a consistent story: supervision appears to be as much of an active ingredient in disulfiram’s success as the drug itself.

Who is disulfiram suitable for — and who should avoid it?

NICE CG115 is specific about where disulfiram fits into treatment. It’s generally considered only after a person has successfully completed alcohol withdrawal, for those with moderate-to-severe alcohol dependence, when the person has a clear personal goal of abstinence (rather than moderation), and when acamprosate or naltrexone aren’t suitable or preferred by the individual.

Before anyone starts disulfiram, NICE recommends a proper medical workup: a comprehensive medical assessment, baseline liver function tests, and a check of urea and electrolytes, alongside a review for any contraindications. This isn’t a formality — it’s a genuine safety screen.

There are real contraindications to be aware of. According to the FDA prescribing information and drugs.com labelling, disulfiram should not be used by people with severe cardiac disease or a history of coronary occlusion, a history of psychosis, or a known hypersensitivity to disulfiram or related thiuram compounds (found in some rubber products and pesticides). NICE adds further caution around use in pregnancy, in people with a history of stroke, hypertension, or severe mental illness.

One of the more serious risks is hepatotoxicity. The FDA label carries a specific warning about rare but serious liver injury, including cholestatic and fulminant hepatitis, with documented cases of liver failure requiring transplant. Importantly, this can occur even after months of otherwise uneventful use — it isn’t necessarily an early reaction — which is exactly why baseline liver function tests and periodic monitoring throughout treatment matter so much.

Other risks that deserve a mention include peripheral neuropathy, psychiatric effects (rare psychotic reactions and the potential to worsen depression in vulnerable individuals), and interactions with other medications, including metronidazole, warfarin and phenytoin. Patient education is also part of the FDA labelling: people on disulfiram are warned to be alert to hidden sources of alcohol that could unexpectedly trigger a reaction, including cooking sauces, vinegars, cough syrups, mouthwash, and even some aftershaves or back rubs applied to the skin.

What does the disulfiram-alcohol reaction actually feel like?

For anyone who hasn’t experienced it, it helps to understand this isn’t a bad hangover — it’s a deliberately engineered acute physical reaction, and it should be treated with the seriousness that implies.

Clinically, the reaction typically follows a recognisable pattern: flushing and a sensation of heat across the face and chest, a throbbing sensation in the head and neck as blood vessels dilate, nausea and vomiting, sweating, thirst, chest pain, heart palpitations, shortness of breath, blurred vision and confusion. Onset is usually rapid — within 10 to 30 minutes of drinking — and how severe it gets depends on both how much disulfiram is in the system and how much alcohol was consumed.

In more severe (though rarer) cases, the reaction can progress to a significant drop in blood pressure, cardiac arrhythmia, collapse, and — very rarely — seizure or cardiovascular collapse. This is precisely why the cardiac contraindications discussed earlier exist: for someone with underlying heart disease, this reaction carries genuine risk, not just discomfort.

This is important information for family members specifically, because it reframes what’s actually at stake. This isn’t a case of someone feeling rough the next morning. It’s an acute reaction that can escalate quickly, which is exactly why unsupervised or impulsive drinking on disulfiram is genuinely dangerous, not merely unpleasant to sit through. It’s also exactly why disulfiram is meant to be prescribed and managed within a monitored medical setting, rather than handed over and left to chance.

How Holina Rehab uses disulfiram in treatment

Given everything the evidence shows, disulfiram at Holina Rehab is treated as one tool inside a broader, medically supervised programme — never as a standalone solution. That positioning isn’t a marketing choice; it follows directly from what the research above actually demonstrates: disulfiram works best under supervision, and loses its effectiveness without it.

In practice, that means disulfiram is only ever considered after medically supervised detox has been completed and the person has been alcohol-free for the required window — it is never started mid-detox, in line with NICE’s guidance on timing. Before any prescription is made, our clinical team carries out a full medical and psychiatric review, covering cardiac history, liver function and mental health screening, mirroring the pre-treatment workup NICE recommends.

Because the evidence so clearly shows that unsupervised use underperforms, supervision isn’t left to chance or to willpower. During the residential phase of treatment, Holina’s clinical team — not the client alone — oversees administration. As discharge planning begins, that same principle carries forward into structuring family or carer-supported supervision at home, which is consistent with NICE’s own recommendation that a properly informed family member or carer be involved in overseeing dosing where possible.

Disulfiram is never used in isolation — it sits alongside the Dual Treatment programme‘s core modalities. NARM and Somatic Therapy address the trauma and nervous-system patterns that often sit underneath drinking behaviour, which no deterrent medication can touch on its own. Family therapy ensures relatives understand what the medication does, what it doesn’t do, and what their role in supervision actually looks like. HBOT forms part of the physical recovery protocol supporting the body through this stage of treatment, and mindfulness and Buddhist-influenced practice support craving and stress regulation more directly than disulfiram’s secondary dopaminergic effect can.

Long-term monitoring is where Jørgensen and colleagues identified a real gap in the evidence — a lack of robust long-term trial data. Holina’s Thrucare programme, two years of structured aftercare, is designed to be the mechanism that fills that gap in practice: ongoing check-ins, relapse-prevention planning, and clinical review of whether disulfiram should continue, be adjusted, or be discontinued as a person’s behavioural health stabilises over time. It is this ongoing dual treatment structure — medication paired with sustained clinical and therapeutic oversight — that reflects what the research consistently points to as the difference between disulfiram that works and disulfiram that doesn’t. If you’d like to discuss whether this fits a loved one’s situation, you can speak with our admissions team directly.

What families can do now

If a loved one has been prescribed disulfiram, the most useful thing you can do is treat it as one part of a plan, not a solved problem. Ask the clinical team directly what the supervision plan looks like, since NICE specifically recommends that a carer or family member be involved in overseeing dosing. Holina’s support for families is built around exactly this kind of involvement.

It’s worth learning the signs of the disulfiram-alcohol reaction described above, so you can recognise it if it happens and understand the difference between symptoms that need to be monitored and symptoms that require immediate medical attention — chest pain, fainting, or difficulty breathing should always be treated as an emergency.

Ask what else is happening alongside the medication: has detox genuinely been completed, what therapy is running in parallel, and what the aftercare plan looks like. This matters because, as the evidence shows, disulfiram has the weakest standalone evidence of the currently approved medications — it was never designed to carry a recovery on its own. For a closer look at how disulfiram compares with other options, see our guide to Suboxone vs Naltrexone vs Methadone.

Finally, try to avoid slipping into a policing or surveillance dynamic, which can damage trust and recovery motivation. Ask the clinical team how to support supervision constructively rather than adversarially, and in early treatment, it’s worth keeping a mental list — or a visible one — of hidden-alcohol products in the home, from cooking sauces to mouthwash, so nobody is caught out by accident. If you’re not sure where to start, our admissions team is glad to walk you through it — you can speak with our admissions team at any time.

Frequently asked questions

Is Antabuse the same as disulfiram?

Yes. Antabuse is the original brand name under which disulfiram was first marketed, and generic disulfiram tablets contain the same active compound, working through the exact same mechanism of ALDH inhibition described above.

How long do I have to stay off alcohol before starting disulfiram?

NICE guidance specifies a minimum of 24 hours after the last drink before starting disulfiram, and this only happens after medically supervised withdrawal has been fully completed — it is never started during active detox.

What’s the typical dose?

NICE Clinical Guideline CG115 lists a standard maintenance dose of 200mg per day, though the exact regimen is always tailored to the individual based on a full medical assessment carried out beforehand.

How long does the reaction last if I drink on disulfiram?

Symptoms typically begin within 10 to 30 minutes of drinking and can last anywhere from 30 minutes to several hours, depending on how much alcohol was consumed and how much disulfiram is active in the system.

Can disulfiram damage my liver?

Yes, this is a documented risk. The FDA label carries a specific warning about rare but serious hepatotoxicity, including hepatitis and cases of liver failure, which is exactly why baseline and periodic liver function testing is a required part of treatment.

Does disulfiram treat cravings?

Not directly. Its primary action is as a deterrent through the aversive physical reaction described above, though a secondary effect on dopamine may modestly influence cravings. It does not address the underlying psychological or emotional drivers of drinking on its own.

Why do some studies say disulfiram doesn’t work?

Meta-analyses have found that disulfiram is effective in supervised, open-label settings but shows no advantage over placebo in blinded or unsupervised trials. Supervision appears to be the deciding factor in whether it produces a meaningful effect.

Who shouldn’t take disulfiram?

People with severe cardiac disease, a history of psychosis, or a known hypersensitivity to disulfiram or thiuram compounds should not take it. Caution is also required in pregnancy and alongside certain other medications, including metronidazole, warfarin and phenytoin.

Is disulfiram a substitute for rehab or therapy?

No. Clinical guidance and the research evidence both position disulfiram as an adjunct within a supervised, psychologically supported programme, not as a standalone treatment for alcohol dependence.

How long do people typically stay on disulfiram?

This varies by individual and is a matter of ongoing clinical judgment. NICE recommends supervision at least every two weeks for the first two months of treatment, then monthly for a further four months, with continued review after that based on progress.

Clinically reviewed by Dr. Natalie Lindemann — Clinical Director, Holina Global · Last reviewed 18 August 2026.